![Stefani Wolff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stefani Wolff
No más puestos en curso
Fortuna: 96 280 $ al 31/05/2024
Historial de carrera de Stefani Wolff
Antiguos cargos conocidos de Stefani Wolff.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
RAIN ONCOLOGY INC. | Director/Miembro de la Junta | 01/03/2021 | 25/01/2024 |
Independent Dir/Board Member | 01/03/2021 | 25/01/2024 | |
NURIX THERAPEUTICS, INC. | Director de Operaciones | 14/06/2021 | 02/05/2023 |
PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01/01/2017 | 28/09/2020 |
BioPharma Consulting Services LLC | Corporate Officer/Principal | 01/05/2016 | 01/01/2017 |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/05/2013 | 01/12/2015 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director/Miembro de la Junta | 01/04/2007 | 01/08/2010 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/09/1989 | 01/04/1997 |
Formación de Stefani Wolff.
The University of North Carolina at Charlotte | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Operativa
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 7 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
NURIX THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Principia Biopharma, Inc.
![]() Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Onyx Pharmaceuticals, Inc.
![]() Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
BioPharma Consulting Services LLC | |
Rain Oncology, Inc.
![]() Rain Oncology, Inc. BiotechnologyHealth Technology Rain Oncology, Inc. is a clinical-stage precision oncology company, which focuses on developing and implement the precision oncology therapies for patients suffering from cancer. The company was founded by Avanish Vellanki and Robert Doebele in April 2017 and is headquartered in Newark, CA. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Stefani Wolff
- Experiencia